ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent Transcription Replication Conflicts in Triple Negative Breast Cancer
S. Lago, V. Poli, L. Fol, M. Botteon, A. Fasciani, A. Turdo, M. Gaggianesi, M. Todaro, Y. Ciani, G. D Amato, F. Demichelis, a. Zippo
The paper identifies ANP32E as a driver of vulnerability to ATR inhibitors in triple-negative breast cancer by promoting R-loop-dependent transcription replication conflicts and genomic instability.
bioRxiv · Mar 25, 2024Cancer Biology